What Researchers Did
Researchers conducted a review to explore the potential mechanisms and therapeutic time window of hyperbaric oxygen therapy in acute ischaemic stroke.
What They Found
The review highlighted that stroke is the fourth leading cause of death in the United States. It noted that in August 2013, the US FDA recognised artery occlusion as one of 13 specific indications for hyperbaric oxygen therapy, though the mechanisms for ischaemic stroke remain unclear.
Canadian Relevance
This review does not have a direct Canadian connection.
Study Limitations
As a review, this study's findings are limited by the current lack of clear understanding regarding the mechanisms, optimal therapeutic time window, and dosing of hyperbaric oxygen therapy for acute ischaemic stroke.